提[3,2-b]里丁:对于具有可变结合方式的未被探索的蛋白激酶的高度选择性抑制剂具有吸引力的支架
Paula Martín Moyano1,2, Tadeáš Kubina1, Štěpán Owen Paruch1
1Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, Brno, 625 00, Czech Republic.
Angewandte Chemie (International ed. in English)
|November 6, 2024
概括
研究人员开发了具有高选择性的新型[3,2-b]氨酸激酶抑制剂. 虽然已确定有效的哈斯激酶抑制剂,但它们在癌细胞中没有表现出细胞毒性作用.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蛋白激酶调节重要的生物过程;异常活动与癌症等疾病有关.
- 开发选择性激酶抑制剂对于向治疗至关重要.
研究的目的:
- 为了识别新型,高度选择性的激酶抑制剂,使用基[3,2-b]胺基架.
- 探索这种支架在准哈斯和CDKL等激酶方面的潜力.
主要方法:
- 提[3,2-b]二衍生物的设计和合成.
- 激酶抑制分析和选择性测试.
- 在药周围绘制化学空间.
主要成果:
- 基于[3,2-b]里丁基架的新一系列高度选择性激酶抑制剂的鉴定.
- 发现了选择性的哈斯激酶抑制剂,包括MU1920,适用于体内研究.
- 证明仅哈斯抑制对癌细胞细胞毒性是不足的.
结论:
- 基[3,2-b]里丁基架为ATP竞争性,非ATP模拟性激酶抑制剂提供了一个多功能模板.
- 这种支架可以用来准未经探索的激酶,如CDKLs.
- 需要进一步的研究来将哈斯抑制转化为有效的癌症疗法.
相关概念视频
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K


